During LTBI, T2DM patients have diminished type 1 (TNF, IL-2 and IFN-γ), type 17 (IL-17F), pro-inflammatory (IL-1 and IL-18) cytokines, as well as the anti-inflammatory cytokine IL-10 (89). The gene discussed is IL1B; the disease is type 2 diabetes mellitus.